种族、族裔与性别在儿童眼病研究组临床研究中的代表性分析
该横断面分析纳入1997年12月1日至2022年9月12日美国儿童眼病研究组(PEDIG)的41项临床研究、共11658名受试者,与2010年美国人口普查儿童数据比较。白人受试者占比过高(超额代表差ECD 0.19,95%CI 0.10-0.28,P<.001),黑人、亚裔和西班牙裔占比过低(ECD分别为-0.07、-0.03和-0.09,均P<.001),女性占比与普查相当(ECD 0.004,95%CI -0.036至0.045,P=.21)。西班牙裔入组比例呈上升趋势(CAGR 7.2%),白人和亚裔呈下降趋势。
要点
- 41项PEDIG临床研究中白人受试者占比显著高于2010年美国儿童普查比例(ECD 0.19)。
- 黑人、亚裔和西班牙裔受试者占比显著低于普查比例(ECD分别为-0.07、-0.03、-0.09)。
- 女性受试者占比与普查比例无显著差异(ECD 0.004,P=.21)。
核心结论
- 在PEDIG临床研究中,黑人、西班牙裔和亚裔受试者占比过低,白人受试者占比过高,女性受试者占比与普查比例相当。
- 趋势显示西班牙裔入组比例上升,白人入组比例下降。
- 本研究提示有机会倡导增加 underrepresented 群体在儿童眼科临床研究中的入组。
研究设计与样本
- 横断面分析,纳入1997年12月1日至2022年9月12日美国PEDIG临床研究,41项符合纳入标准(已完成、研究人群<18岁、至少1篇伴随发表)。
- 共纳入11658名研究参与者,平均(SD)年龄5.9(2.8)岁,5918名(50.8%)为女性。
- 数据来自同行评议发表、患者入组数据集和ClinicalTrials.gov;数据分析于2023年11月至2024年2月进行。
主要发现
- 白人参与者占比过高(ECD 0.19,95%CI 0.10-0.28,P<.001)。
- 黑人参与者占比过低(ECD -0.07,95%CI -0.10至-0.03,P<.001)。
- 亚裔参与者占比过低(ECD -0.03,95%CI -0.04至-0.02,P<.001)。
- 西班牙裔参与者占比过低(ECD -0.09,95%CI -0.13至-0.05,P<.001)。
- 女性参与者占比与普查比例相当(ECD 0.004,95%CI -0.036至0.045,P=.21)。
关键数值与推荐
- 比例入组定义为单样本Wilcoxon秩检验P≥.05时无差异。
- 若P<.05,则比较中位入组百分比与2010年美国普查比例,判断占比过低或过高。
- ECD定义为组中位入组百分比与2010年美国普查百分比的差值。
临床怎么用
- 原文未据此给出临床推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Racial, ethnic, and sex disparities exist in US clinical study enrollment, and the prevalence of these disparities in Pediatric Eye Disease Investigator Group (PEDIG) clinical studies has not been thoroughly assessed. OBJECTIVE: To evaluate racial, ethnic, and sex representation in PEDIG clinical studies compared with the 2010 US Census pediatric population. DESIGN, SETTING, AND PARTICIPANTS: This cross-sectional analysis examined PEDIG clinical studies based in the US from December 1, 1997 to September 12, 2022, 41 of which met inclusion criteria of a completed study, a study population younger than 18 years, and 1 or more accompanying publication. Data analysis was performed between November 2023 and February 2024. EXPOSURE: Study participant race, ethnicity, and sex for each clinical study, as collected from peer-reviewed publications, patient-enrollment datasets, and ClinicalTrials.gov. MAIN OUTCOMES AND MEASURES: Median enrollment percentages of female, White, Black, Hispanic, Asian, and other race participants were calculated and compared with the 2010 US Census pediatric population using a 1-sample Wilcoxon rank test. Proportionate enrollment was defined as no difference on a 1-sample Wilcoxon rank test if P ≥ .05. If P < .05, we determined if the median enrollment percentage was greater than or less than 2010 US Census proportion to determine if enrollees were underrepresented or overrepresented. To calculate the magnitude of overrepresentation or underrepresentation, enrollment-census difference (ECD) was defined as the difference between groups' median enrollment percentage and percentage representation in the 2010 US Census. Compound annual growth rate (CAGR) was used to measure temporal trends in enrollment, and logistic regression analysis was used to analyze factors that may have contributed to proportionate representation outcomes. RESULTS: A total of 11 658 study participants in 41 clinical studies were included; mean (SD) participant age was 5.9 (2.8) years and 5918 study participants (50.8%) were female. In clinical studies meeting inclusion criteria, White participants were overrepresented (ECD, 0.19; 95% CI, 0.10-0.28; P < .001). Black participants (ECD, -0.07; 95% CI, -0.10 to -0.03; P < .001), Asian participants (ECD, -0.03; 95% CI, -0.04 to -0.02; P < .001), and Hispanic participants (ECD, -0.09; 95% CI, -0.13 to -0.05; P < .001) were underrepresented. Female participants were represented proportionately (ECD, 0.004; 95% CI, -0.036 to 0.045; P = .21). White and Asian participants demonstrated a decreasing trend in study enrollment from 1997 to 2022 (White: CAGR, -1.5%; 95% CI, -2.3% to -0.6%; Asian: CAGR, -1.7%; 95% CI, -2.0% to -1.4%), while Hispanic participants demonstrated an increasing enrollment trend (CAGR, 7.2%; 95% CI, 3.7%-10.7%). CONCLUSIONS AND RELEVANCE: In this retrospective cross-sectional study of PEDIG clinical studies from December 1, 1997 to September 12, 2022, Black, Hispanic, and Asian participants were underrepresented, White participants were overrepresented, and female participants were represented proportionally. Trends suggested increasing enrollment of Hispanic participants and decreasing enrollment of White participants over time. This study demonstrates an opportunity to advocate for increased enrollment of underrepresented groups in pediatric ophthalmology clinical studies.
引用
- Dihan QA, Alzein AF, Ibrahim OM, et al. Race, Ethnicity, and Sex in Pediatric Eye Disease Investigator Group Clinical Studies. JAMA Ophthalmol. 2024. PMID: 39235786. doi:10.1001/jamaophthalmol.2024.3281
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。